JP2004500355A5 - - Google Patents

Download PDF

Info

Publication number
JP2004500355A5
JP2004500355A5 JP2001541871A JP2001541871A JP2004500355A5 JP 2004500355 A5 JP2004500355 A5 JP 2004500355A5 JP 2001541871 A JP2001541871 A JP 2001541871A JP 2001541871 A JP2001541871 A JP 2001541871A JP 2004500355 A5 JP2004500355 A5 JP 2004500355A5
Authority
JP
Japan
Prior art keywords
substituted
embedded image
alkyl
alkenyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2001541871A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004500355A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/032679 external-priority patent/WO2001040185A1/en
Publication of JP2004500355A publication Critical patent/JP2004500355A/ja
Publication of JP2004500355A5 publication Critical patent/JP2004500355A5/ja
Abandoned legal-status Critical Current

Links

JP2001541871A 1999-12-01 2000-12-01 ニューロンの生長及び伸長を刺激する化合物、組成物及び方法 Abandoned JP2004500355A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16824699P 1999-12-01 1999-12-01
PCT/US2000/032679 WO2001040185A1 (en) 1999-12-01 2000-12-01 Compounds, compositions, and methods for stimulating neuronal growth and elongation

Publications (2)

Publication Number Publication Date
JP2004500355A JP2004500355A (ja) 2004-01-08
JP2004500355A5 true JP2004500355A5 (cg-RX-API-DMAC10.html) 2008-01-10

Family

ID=22610717

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001541871A Abandoned JP2004500355A (ja) 1999-12-01 2000-12-01 ニューロンの生長及び伸長を刺激する化合物、組成物及び方法

Country Status (18)

Country Link
US (1) US6544987B2 (cg-RX-API-DMAC10.html)
EP (1) EP1237869A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004500355A (cg-RX-API-DMAC10.html)
AR (1) AR029411A1 (cg-RX-API-DMAC10.html)
AU (1) AU1810001A (cg-RX-API-DMAC10.html)
BR (1) BR0016150A (cg-RX-API-DMAC10.html)
CA (1) CA2389368A1 (cg-RX-API-DMAC10.html)
CO (1) CO5261615A1 (cg-RX-API-DMAC10.html)
DO (1) DOP2000000107A (cg-RX-API-DMAC10.html)
GT (1) GT200000203A (cg-RX-API-DMAC10.html)
HK (1) HK1048987A1 (cg-RX-API-DMAC10.html)
HN (1) HN2000000268A (cg-RX-API-DMAC10.html)
MX (1) MXPA02005510A (cg-RX-API-DMAC10.html)
PA (1) PA8508001A1 (cg-RX-API-DMAC10.html)
PE (1) PE20011101A1 (cg-RX-API-DMAC10.html)
SV (1) SV2002000233A (cg-RX-API-DMAC10.html)
UY (1) UY26464A1 (cg-RX-API-DMAC10.html)
WO (1) WO2001040185A1 (cg-RX-API-DMAC10.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405234B2 (en) * 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
EP1567487A4 (en) * 2002-11-15 2005-11-16 Bristol Myers Squibb Co OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION
US7820702B2 (en) * 2004-02-04 2010-10-26 Bristol-Myers Squibb Company Sulfonylpyrrolidine modulators of androgen receptor function and method
US7388027B2 (en) * 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
CA2881078C (en) 2004-06-24 2018-10-02 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
US7544171B2 (en) * 2004-10-22 2009-06-09 General Patent Llc Methods for promoting nerve regeneration and neuronal growth and elongation
US7988648B2 (en) * 2005-03-04 2011-08-02 General Patent, Llc Pancreas regeneration treatment for diabetics using extracorporeal acoustic shock waves
WO2006106423A2 (en) * 2005-04-07 2006-10-12 Pfizer Inc. Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase
DK1928886T3 (da) 2005-09-09 2011-07-11 Glaxosmithkline Llc Pyridin-derivater og deres anvendelse i behandlingen af psykotiske lidelser
US7419394B2 (en) * 2005-11-11 2008-09-02 Rockwell Automation Technologies, Inc. Electrical system having withdrawable unit with maintained control and communication connection
WO2007075901A2 (en) * 2005-12-24 2007-07-05 Vertex Pharmaceuticals Incorporated Quinolin- 4 - one derivatives as modulators of abc transporters
LT1993360T (lt) 2005-12-28 2017-06-12 Vertex Pharmaceuticals Incorporated N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
CN101569864B (zh) * 2008-04-29 2011-08-03 中山大学 手性磺胺类有机小分子催化剂及其应用
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
SI3330255T1 (sl) 2009-03-20 2021-03-31 Vertex Pharmaceuticals Incorporated Postopek izdelave regulatorja transmembranske prevodnosti pri cistični fibrozi
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2819670B1 (en) 2012-02-27 2026-05-20 Vertex Pharmaceuticals Incorporated Pharmaceutical Composition and Their Administration
CA2963945C (en) 2014-10-07 2023-01-10 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
US11389370B2 (en) 2016-04-18 2022-07-19 Softwave Tissue Regeneration Technologies, Llc Treatments for blood sugar levels and muscle tissue optimization using extracorporeal acoustic shock waves
US11389372B2 (en) 2016-04-18 2022-07-19 Softwave Tissue Regeneration Technologies, Llc Acoustic shock wave therapeutic methods
US11458069B2 (en) 2016-04-18 2022-10-04 Softwave Tissue Regeneration Technologies, Llc Acoustic shock wave therapeutic methods to treat medical conditions using reflexology zones
US11389371B2 (en) 2018-05-21 2022-07-19 Softwave Tissue Regeneration Technologies, Llc Acoustic shock wave therapeutic methods
US11389373B2 (en) 2016-04-18 2022-07-19 Softwave Tissue Regeneration Technologies, Llc Acoustic shock wave therapeutic methods to prevent or treat opioid addiction
WO2019152527A1 (en) * 2018-01-30 2019-08-08 Board Of Regents, The University Of Texas System Pipecolic esters for inhibition of the proteasome
WO2022270628A1 (ja) * 2021-06-25 2022-12-29 国立大学法人 大分大学 Rsウイルス感染症の処置および/または予防用医薬としてのヘテロシクロアルキル置換ポリヘテロアゾール誘導体
US12402898B2 (en) 2023-01-27 2025-09-02 Softwave Tissue Regeneration Technologies, Llc Acoustic shock wave or pressure pulse treatment for proptosis or exophthalmos

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187500B1 (en) 1984-12-20 1993-04-28 The Upjohn Company Monobactams
US5192773A (en) 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5244905A (en) 1990-08-31 1993-09-14 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl polyhydro-β-carboline-phenylalanine- and phenethylamine derivatives
US5219851A (en) 1991-03-05 1993-06-15 Warner-Lambert Company Tetrahydroisoquinoline-type renin inhibiting peptides
DE4141218A1 (de) 1991-12-13 1993-06-17 Luitpold Werk Chem Pharm Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel
DE4217719A1 (de) 1992-05-29 1993-12-02 Bayer Ag Zweifach heterocyclisch substituierte Sulfonylamino(thio)carbonylverbindungen
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5612350A (en) 1993-11-30 1997-03-18 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements
US5494925A (en) 1994-12-02 1996-02-27 Sterling Winthrop Inc. 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5541168A (en) 1994-12-02 1996-07-30 Sterling Winthrop Inc. Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5556909A (en) 1994-12-02 1996-09-17 Sanofi Winthrop Inc. Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
GB9521322D0 (en) 1995-10-17 1995-12-20 Sandoz Ltd Organic compounds
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
DE19542189A1 (de) 1995-11-13 1997-05-15 Hoechst Ag Cyclische N-substituierte alpha-Iminohydroxamsäuren
TR199800849T2 (xx) 1995-11-13 1998-07-21 Hoechst Aktiengesellschaft Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
JP3563411B2 (ja) 1997-01-23 2004-09-08 エフ・ホフマン−ラ ロシュ アーゲー スルファミド−メタロプロテアーゼ阻害剤
US5721256A (en) * 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
GB9804426D0 (en) * 1998-03-02 1998-04-29 Pfizer Ltd Heterocycles
US6121280A (en) 1998-03-24 2000-09-19 Pfizer Inc. Azabicyclic rotomase inhibitors
JP2002516857A (ja) 1998-06-02 2002-06-11 ブリストルーマイヤーズ スクイブ カンパニー 神経栄養性ジフルオロアミド剤
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
OA11584A (en) 1998-07-21 2004-07-20 Warner Lambert Co Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions.
GB9815880D0 (en) 1998-07-21 1998-09-16 Pfizer Ltd Heterocycles
AU1902899A (en) 1998-09-18 2000-04-10 Amgen, Inc. Bridged heterocyclic derivatives
AU3221300A (en) 1999-02-03 2000-08-25 Schering Aktiengesellschaft Carboxylic acid derivatives, process for their preparation and their use as rotamase enzyme activity inhibitors

Similar Documents

Publication Publication Date Title
WO2001040185B1 (en) Compounds, compositions, and methods for stimulating neuronal growth and elongation
ES2308839T3 (es) Amidas n,n-disustituidas que inhiben la union de integrinas a sus receptores.
CY1109273T1 (el) Ενωσεις πιπεριδινης και φαρμακευτικες συνθεσεις που τις περιεχουν
JP2002539128A5 (cg-RX-API-DMAC10.html)
RU2007101685A (ru) Модуляторы никотиновых ацетилхолиновых рецепторов альфа 7 и их терапевтические применения
RU2002118705A (ru) Производные 4-аминопиперидина и их применение в качестве лекарственного средства
RU2005103244A (ru) Производные 1h-1,2,4-триазол-3-карбоксамида в качестве лигандов рецептора каннабиноидов (cb1)
JP2003529596A5 (cg-RX-API-DMAC10.html)
JP2012504133A5 (cg-RX-API-DMAC10.html)
JP2003531821A5 (cg-RX-API-DMAC10.html)
RU2006116889A (ru) Производные n-гетероциклилметилбензамидов, их получение и их применение в терапии
JP2004533444A5 (cg-RX-API-DMAC10.html)
EA200300424A1 (ru) Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов
PL365163A1 (en) Aryl fused azapolycyclic compounds
DE60322680D1 (de) Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen
RU2394031C2 (ru) Соли четвертичного аммония в качестве антагонистов м3
RU2015121044A (ru) Производные фенилэтилпиридина в качестве ингибиторов pde4
RU2002133458A (ru) Соединения пиперазина и пиперидина
RU2003131970A (ru) Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием
JP2003529597A5 (cg-RX-API-DMAC10.html)
RU2007128080A (ru) Производные пирролидиния в качестве мускариновых рецепторов мз
JP2003529598A5 (cg-RX-API-DMAC10.html)
JP2003516994A5 (cg-RX-API-DMAC10.html)
ES2339021T3 (es) Derivados de alfa-aminoamida utiles como agentes antiinflamatorios.